Hongzhi Qiao Selected Research

Hongzhi Qiao Research Topics

Disease

16	Neoplasms (Cancer) 03/2023 - 09/2014
4	Inflammation (Inflammations) 03/2024 - 08/2020
3	Fibrosis (Cirrhosis) 08/2020 - 08/2014
3	Breast Neoplasms (Breast Cancer) 02/2019 - 01/2017
2	Ulcerative Colitis 09/2021 - 07/2014
1	Wounds and Injuries (Trauma) 03/2024
1	Bacterial Infections (Bacterial Infection) 03/2024
1	Bites and Stings (Sting) 03/2023
1	Kidney Calculi (Kidney Stone) 01/2023
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2021
1	Yin Deficiency (Yinxu) 12/2021
1	Sepsis (Septicemia) 12/2021
1	Colitis 09/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 02/2021
1	Cardiotoxicity 01/2021
1	Colonic Neoplasms (Colon Cancer) 10/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2017
1	Neoplasm Metastasis (Metastasis) 10/2017
1	Lymphoma (Lymphomas) 01/2017
1	Edema (Dropsy) 01/2017

Drug/Important Bio-Agent (IBA)

3	CopperIBA 12/2021 - 10/2020
3	IronIBA 08/2020 - 01/2019
2	HydrogelsIBA 03/2024 - 01/2023
2	Therapeutic UsesIBA 09/2021 - 10/2017
2	Proteins (Proteins, Gene)FDA Link 02/2021 - 12/2017
2	Small Interfering RNA (siRNA)IBA 02/2021 - 09/2014
2	Liposomes (Liposome)IBA 01/2021 - 10/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2017
2	ChitosanIBA 12/2017 - 08/2014
2	catechol (pyrocatechol)IBA 12/2017 - 08/2014
1	CollagenIBA 03/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2024
1	ExotoxinsIBA 03/2024
1	Mitochondrial DNA (mtDNA)IBA 03/2023
1	Immune Checkpoint InhibitorsIBA 03/2023
1	Drug CombinationsIBA 01/2023
1	Cardiac GlycosidesIBA 01/2023
1	oleandrinIBA 01/2023
1	Calcium OxalateIBA 01/2023
1	Interleukin-17 (Interleukin 17)IBA 12/2021
1	Interleukin-22 (IL-22)IBA 12/2021
1	CytokinesIBA 12/2021
1	Phenol (Carbolic Acid)FDA Link 12/2021
1	Imiquimod (Aldara)FDA LinkGeneric 12/2021
1	Enhancer of Zeste Homolog 2 ProteinIBA 09/2021
1	veronicastrosideIBA 09/2021
1	FlavonoidsIBA 09/2021
1	InflammasomesIBA 09/2021
1	Histone MethyltransferasesIBA 09/2021
1	MetalsIBA 02/2021
1	Antineoplastic Agents (Antineoplastics)IBA 02/2021
1	Adenosine Triphosphate (ATP)IBA 02/2021
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2021
1	Surface-Active Agents (Surfactants)IBA 01/2021
1	bufalinIBA 01/2021
1	trans-crotonin (CTN)IBA 10/2020
1	GoldIBA 10/2020
1	Hyaluronic Acid (Hyaluronan)IBA 10/2020
1	AntioxidantsIBA 08/2020
1	Polysaccharides (Glycans)IBA 08/2020
1	LipidsIBA 08/2020
1	Contrast MediaIBA 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 10/2019
1	Wheat Germ AgglutininsIBA 10/2019
1	Betulinic AcidIBA 02/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2019
1	PolymersIBA 01/2019
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 02/2018
1	EstersIBA 02/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2018
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2018
1	ProdrugsIBA 01/2018
1	tocophersolanIBA 01/2018
1	MicellesIBA 01/2018
1	Tocopherols (Tocopherol)IBA 01/2018
1	Succinic Acid (Succinate)IBA 01/2018
1	Polyethylene (Polythene)IBA 01/2018
1	salvianolic acid BIBA 12/2017
1	Coloring Agents (Dyes)IBA 10/2017
1	CXCR4 Receptors (CXCR4 Receptor)IBA 10/2017
1	plerixafor FDA Link 10/2017
1	Phospholipids (Phosphatides)FDA LinkGeneric 10/2017
1	homocamptothecinIBA 04/2017
1	PowdersIBA 01/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017
1	Superoxide DismutaseIBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	LigandsIBA 01/2017
1	Interleukin-1 (Interleukin 1)IBA 01/2017

Therapy/Procedure

9	Therapeutics 03/2024 - 07/2014
2	Lasers (Laser) 01/2019 - 10/2017
1	Aftercare (After-Treatment) 03/2024
1	Microspheres (Microsphere) 01/2023
1	Immunotherapy 01/2023
1	Oral Administration 01/2023
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2021
1	Precision Medicine 01/2020
1	Drug Therapy (Chemotherapy) 01/2019
1	Photothermal Therapy 01/2019
1	Intravenous Injections 09/2014